Back in 2003, the U.S. Food and Drug Administration (FDA) required that a particular class of antidepressants called selective serotonin reuptake inhibitors (SSRI) carry a “black box” warning that for children and teens, side effects may include an increased risk of suicidal thoughts. Sounds perfectly reasonable, doesn’t it? But then, along comes the Law of...Continue reading